首页> 外文期刊>Michigan Academician >Biochemistry & Molecular Biology
【24h】

Biochemistry & Molecular Biology

机译:生物化学与分子生物学

获取原文
获取原文并翻译 | 示例
       

摘要

Practicing recombinant DNA technology has shown great potential to decrease both the cost and the environmental impact of developing important prenyl-based drugs such as the anti-malarial artemisinin and tumor-suppressor Taxol. For reasons not fully understood, progress has been limited by the decreased cell growth of bacterial hosts used to produce these drugs. The cause of death is suspected to be toxicity of isoprenoid precursors. We studied the effects of decreasing the levels of the putative toxic compounds, DMAPP and IPP, by expressing an isoprene synthase from poplar in E. coli. As this enzyme uses DMAPP as a substrate to produce the volatile and releasable isoprene, we hypothesize that its activity could be used to relieve the cytotoxicity. The isoprene synthase expression was varied and paired with increased flux through a heterologous isoprenoid pathway in order to test the hypothesis and examine the influence of intermediate levels on cytotoxicity.
机译:实践中的重组DNA技术已显示出巨大的潜力,可以降低开发重要的异戊二烯基药物(如抗疟疾青蒿素和抑癌紫杉醇)的成本和对环境的影响。由于尚未完全理解的原因,进展一直受到用于生产这些药物的细菌宿主细胞生长减少的限制。死亡原因被怀疑是类异戊二烯前体的毒性。我们通过在大肠杆菌中表达白杨的异戊二烯合酶,​​研究了降低假定的有毒化合物DMAPP和IPP含量的影响。由于这种酶使用DMAPP作为底物来生产挥发性和可释放的异戊二烯,因此我们假设其活性可用于缓解细胞毒性。异戊二烯合酶的表达是变化的,并且与通过异源类异戊二烯途径的通量增加配对,以检验假设并检验中间水平对细胞毒性的影响。

著录项

  • 来源
    《Michigan Academician》 |2015年第3期|306-309|共4页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 01:15:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号